NCT02857400 2026-04-14
CREDO
Institut Claudius Regaud
Phase NA Completed
Clinical Trials
1,840 trialsNCT03956459 2026-04-14
IQversusMI
Institut Claudius Regaud
Phase NA Completed
NCT05377554 2026-04-13
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT05909202 2026-04-13
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT01445509 2026-04-06
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01968109 2026-04-06
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT06238687 2026-04-06
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2 Completed
NCT04309578 2026-04-03
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Phase 2 Completed
NCT02379416 2026-04-01
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04050709 2026-04-01
QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
ImmunityBio, Inc.
Phase 1 Completed
NCT05516914 2026-04-01
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
NCT03449381 2026-03-31
This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Completed
NCT04809740 2026-03-31
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
University of Alabama at Birmingham
Phase NA Completed
NCT02133625 2026-03-30
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Dana-Farber Cancer Institute
Phase 1 Completed
NCT04055948 2026-03-30
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients
Case Comprehensive Cancer Center
Phase NA Completed
NCT07495553 2026-03-30
Web Based
Ondokuz Mayıs University
Phase NA Completed
NCT06318338 2026-03-27
Virtual Reality to Promote Relaxation Prior to Simulation
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03568058 2026-03-24
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
University of California, San Diego
Phase 1 Completed
NCT05046171 2026-03-24
Decreasing Polypharmacy in Older Adults With Curable Cancers Trial
University of Rochester
Phase 1/2 Completed
NCT06807216 2026-03-24
YATAC
Defactum, Central Denmark Region
Phase NA Completed
NCT02517281 2026-03-20
SKINTARGET
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed
NCT03328663 2026-03-20
Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant
Massachusetts General Hospital
Phase NA Completed
NCT05508412 2026-03-18
CancerPEP
Nova Scotia Health Authority
Phase NA Completed
NCT06298357 2026-03-18
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
University of Alabama at Birmingham
Phase 1 Completed
NCT00420563 2026-03-16
PAL-ANGI
Centre Oscar Lambret
Phase 2 Completed
NCT01374620 2026-03-16
PAL-ANGI2
Centre Oscar Lambret
Phase 1 Completed
NCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
NCT00580515 2026-03-13
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03833167 2026-03-10
KEYNOTE-630
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT07460570 2026-03-10
N-PELTP
Sultan Qaboos University
Phase NA Completed
NCT02423057 2026-03-06
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02840058 2026-03-06
ITHER
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT06048822 2026-03-06
Enhancing Cancer Survivorship With Pickleball
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT06248450 2026-03-06
YouCanPrefer
Linkoeping University
Phase NA Completed
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT05564468 2026-02-27
Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer
Fred Hutchinson Cancer Center
Phase NA Completed
NCT06056791 2026-02-27
CaRe
Inmune Bio, Inc.
Phase 1/2 Completed
NCT03976362 2026-02-25
KEYLYNK-008
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05024968 2026-02-25
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03466957 2026-02-20
Individual Approach in Gynecological Cancer Brachytherapy
Institute of Oncology Ljubljana
Phase NA Completed
NCT03964233 2026-02-18
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
Boehringer Ingelheim
Phase 1 Completed
NCT06758011 2026-02-17
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Roswell Park Cancer Institute
Phase NA Completed
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT05490641 2026-02-13
Project KNOWN
The University of Texas at Arlington
Phase NA Completed
NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT03659968 2026-02-11
Initiation of Adapted Physical Activity for Patients With Advanced Pediatric Malignancies
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT01534598 2026-02-10
FdCyd and THU for Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04455698 2026-02-10
ENGAGE
University of Chicago
Phase NA Completed